| Conference II | University of California, Irvine | Stem Cells for Huntington’s Disease (HD) International (SC4HDI) Conference |
$31,727 |
| Late Stage Preclinical Projects | University of California, Irvine | An hESC-derived hNSC Therapeutic for Huntington’s Disease |
$5,635,393 |
| Preclinical Development Awards | University of California, Irvine | A hNSC Development Candidate for Huntington’s Disease |
$4,951,623 |
| Disease Team Planning | University of California, Irvine | Huntington’s Disease Team |
$41,953 |
| Early Translational II | University of California, Irvine | A hESc-based Development Candidate for Huntington’s Disease |
$3,955,038 |
| New Cell Lines | University of California, Irvine | New Cell Lines for Huntington’s Disease |
$1,302,526 |
